News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
196,751 Results
Type
Article (14875)
Company Profile (20)
Press Release (181856)
Multimedia
Podcasts (120)
Webinars (5)
Section
Business (69368)
Career Advice (1625)
Deals (9636)
Drug Delivery (92)
Drug Development (32839)
Employer Resources (79)
FDA (5033)
Job Trends (4712)
News (114534)
Policy (8370)
Tag
2024 BioCapital Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (969)
Accelerated approval (1)
Adcomms (20)
Allergies (37)
Alliances (11704)
ALS (49)
Alzheimer's disease (541)
Antibody-drug conjugate (ADC) (108)
Approvals (5001)
Artificial intelligence (117)
Autoimmune disease (12)
Automation (5)
Bankruptcy (92)
Best Places to Work (3946)
BIOSECURE Act (11)
Biosimilars (55)
Biotechnology (21)
Bladder cancer (39)
Brain cancer (16)
Breast cancer (145)
Cancer (997)
Cardiovascular disease (94)
Career advice (1321)
Career pathing (31)
CAR-T (93)
Cell therapy (245)
Cervical cancer (6)
Clinical research (26655)
Collaboration (264)
Compensation (54)
Complete response letters (14)
COVID-19 (1187)
CRISPR (31)
C-suite (234)
Cystic fibrosis (41)
Data (839)
Decentralized trials (1)
Denatured (42)
Depression (30)
Diabetes (99)
Diagnostics (2040)
Digital health (2)
Diversity (7)
Diversity, equity & inclusion (23)
Drug discovery (46)
Drug pricing (72)
Drug shortages (14)
Duchenne muscular dystrophy (41)
Earnings (18512)
Editorial (31)
Employer branding (8)
Employer resources (76)
Events (21406)
Executive appointments (674)
FDA (5488)
Featured Employer (11)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (300)
Gene editing (66)
Generative AI (11)
Gene therapy (188)
GLP-1 (429)
Government (1589)
Grass and pollen (1)
Guidances (25)
Healthcare (6327)
Huntington's disease (17)
IgA nephropathy (11)
Immunology and inflammation (74)
Indications (9)
Infectious disease (1247)
Inflammatory bowel disease (55)
Inflation Reduction Act (10)
Influenza (19)
Intellectual property (32)
Interviews (332)
IPO (4327)
IRA (27)
Job creations (850)
Job search strategy (1085)
Kidney cancer (6)
Labor market (22)
Layoffs (238)
Leadership (21)
Legal (1325)
Liver cancer (29)
Lung cancer (171)
Lymphoma (71)
Machine learning (5)
Management (29)
Manufacturing (125)
MASH (35)
Medical device (4883)
Medtech (4885)
Mergers & acquisitions (5532)
Metabolic disorders (347)
Multiple sclerosis (35)
NASH (18)
Neurodegenerative disease (54)
Neuropsychiatric disorders (16)
Neuroscience (797)
NextGen: Class of 2025 (2261)
Non-profit (1586)
Northern California (916)
Now hiring (23)
Obesity (204)
Opinion (200)
Ovarian cancer (33)
Pain (32)
Pancreatic cancer (35)
Parkinson's disease (44)
Partnered (10)
Patents (60)
Patient recruitment (52)
Peanut (21)
People (36548)
Pharmaceutical (6)
Pharmacy benefit managers (4)
Phase I (11630)
Phase II (11283)
Phase III (7482)
Pipeline (516)
Policy (96)
Postmarket research (600)
Preclinical (2673)
Press Release (12)
Prostate cancer (50)
Psychedelics (24)
Radiopharmaceuticals (114)
Rare diseases (189)
Real estate (1455)
Recruiting (32)
Regulatory (6209)
Reports (7)
Research institute (852)
Resumes & cover letters (276)
Rett syndrome (4)
RNA editing (3)
RSV (26)
Schizophrenia (37)
Series A (65)
Series B (37)
Sickle cell disease (29)
Southern California (742)
Special edition (10)
Spinal muscular atrophy (61)
Sponsored (11)
Startups (1222)
Stomach cancer (9)
Supply chain (26)
Tariffs (18)
The Weekly (76)
United States (7404)
Vaccines (343)
Venture capitalists (23)
Weight loss (184)
Women's health (22)
Worklife (15)
Date
Today (32)
Last 7 days (276)
Last 30 days (910)
Last 365 days (11578)
2025 (3680)
2024 (12822)
2023 (14649)
2022 (16547)
2021 (18148)
2020 (17272)
2019 (15440)
2018 (11907)
2017 (10792)
2016 (9613)
2015 (10701)
2014 (7662)
2013 (6211)
2012 (6484)
2011 (6760)
2010 (5443)
Location
Africa (352)
Alabama (23)
Alaska (7)
Arizona (38)
Arkansas (6)
Asia (13754)
Australia (2382)
California (2018)
Canada (614)
China (246)
Colorado (105)
Connecticut (104)
Delaware (54)
Europe (32119)
Florida (285)
Georgia (57)
Idaho (26)
Illinois (180)
India (10)
Indiana (103)
Iowa (3)
Japan (78)
Kansas (26)
Kentucky (5)
Louisiana (3)
Maine (13)
Maryland (255)
Massachusetts (1404)
Michigan (50)
Minnesota (129)
Mississippi (1)
Missouri (36)
Montana (6)
Nebraska (7)
Nevada (19)
New Hampshire (41)
New Jersey (544)
New Mexico (8)
New York (604)
North Carolina (341)
North Dakota (1)
Northern California (916)
Ohio (74)
Oklahoma (7)
Oregon (8)
Pennsylvania (448)
Puerto Rico (2)
Rhode Island (29)
South America (443)
South Carolina (5)
Southern California (742)
Tennessee (17)
Texas (268)
Utah (68)
Virginia (40)
Washington D.C. (20)
Washington State (168)
West Virginia (1)
Wisconsin (19)
196,751 Results for "i mab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
I-Mab Cuts 27% of Workforce After Pipeline Re-Prioritization
The layoffs follow an announcement in early January that I-Mab will re-prioritize resources to focus on advancing a CLDN18.2 and 4-1BB bispecific antibody for gastric cancers.
January 29, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025
April 30, 2025
·
4 min read
Press Releases
I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference
March 27, 2025
·
1 min read
Press Releases
I-Mab to Participate in Leerink Partners Global Healthcare Conference
February 18, 2025
·
1 min read
Press Releases
I-Mab Announces Accelerated Givastomig Phase 1b Study Progress
March 10, 2025
·
5 min read
Business
I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer
I-Mab today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer.
June 6, 2024
·
5 min read
Press Releases
I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Press Releases
I-Mab to Participate at the Piper Sandler Healthcare Conference
November 21, 2024
·
1 min read
BioCapital
I-Mab to Participate at the 2024 Jefferies Global Healthcare Conference
I-Mab, a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024.
May 22, 2024
·
1 min read
Press Releases
I-Mab Reports Third Quarter 2024 Results
November 15, 2024
·
17 min read
1 of 19,676
Next
